ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,962 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentOtelfingenPhilochem AG
Philochem AG Logo
Verified· 2 sources

Philochem AG

Summary

About the company

The core activity of Philochem is the development and research of bioactive compounds for cancer treatment, particularly in the areas of Target Discovery, Ligand Discovery and small molecule therapeutics. The company focuses on developing compounds that target the site of the disease while protecting healthy tissue. The company's products include various radiopharmaceuticals for imaging and therapy of cancer, such as 68Ga-OncoFAP, 177Lu-OncoFAP and 68Ga-OncoCAIX.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Pharmaceutical Industry
✓ Offered11
Ligand-based drug discovery and development
Ligand-based targeting, discovery and development of therapeutics based on small organic ligands, cyclic peptides and antibody fragments; validation in disease models and transfer to clinical trials.
DNA-Encoded Chemical Libraries (DELs)
DNA-encoded chemical libraries for discovery of small organic ligands, screening of binders against selected targets, and collaborations or fee-for-service projects.
Cyclic Peptide Phage Libraries
Cyclic peptide phage libraries for isolating target-specific cyclic peptides, used in internal discovery programs and in collaborations with industrial or academic partners.
Antibody Phage Libraries
Antibody phage libraries for isolating human monoclonal antibodies against antigens of interest, used in internal discovery programs and collaborative projects.
Partnering & Fee-For-Services
Collaborations on proprietary small-molecule ligands, DNA-encoded chemical libraries, antibodies and cyclic peptides, including screening projects and licensing agreements.
Small Molecule Therapeutics
Small-molecule therapeutics for tumour targeting, including delivery of radionuclides, cytotoxic agents, immunomodulators and adaptors for universal CAR-T therapy.
Antibody-based Therapeutics
Antibody-cytokine fusion proteins and other antibody-based therapeutics for cancer, with applications also mentioned for inflammatory conditions.
Target identification and chemical proteomics
Discovery and validation of pharmaceutical targets, chemical proteomics, target identification, mass spectrometry-based biodistribution and MHC-I immunopeptidomics.
OncoFAP programmes
OncoFAP-based imaging and therapy programmes for various solid tumours, including 68Ga-, 18F- and 177Lu-based agents and OncoFAP-GlyPro-MMAE.
OncoACP3 programmes
OncoACP3 imaging and therapy programmes for prostate cancer, including 68Ga-, 18F-, 177Lu- and 225Ac-labelled candidates.
OncoCAIX programmes
OncoCAIX imaging and therapy programmes for renal cell carcinoma, including 68Ga-OncoCAIX and 177Lu-OncoCAIX.
Comparisons

Philochem AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Philochem AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Philochem AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Libernstrasse 3
8112 Otelfingen

At a glance

Legal form
Corporation
UID
CHE-113.181.443
Founded
2006 · 20 years
Last commercial register change
August 27, 2025
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Philochem AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

MA
Mabylon AG
Schlieren
NS
Neurimmune Subone AG
Schlieren
NA
Neurimmune AG
Schlieren
BA
BiognoSYS AG
Schlieren
CR
Charles River Laboratories Switzerland AG
Hettlingen
AA
Athebio AG
Schlieren
IG
inSili.com GmbH
Zurich
HA
Haelixa AG
Kemptthal